STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended		31 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012
OPERATING ACTIVITIES:
Net loss	$ (1,417,312)	$ (1,193,838)	$ (3,296,760)
Adjustments to reconcile net loss to net cash in operating activities:
Stock issued for services	0	210,000	210,000
Impairment of investment in joint venture	20,000	0	280,000
Imputed interest expense	40,077	84,126	150,011
Amortization of discount on convertible note payable	1,031,468	72,776	1,104,244
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities	41,668	14,665	28,530
Accrued interest payable	30,344	41,496	100,375
NET CASH USED IN OPERATING ACTIVITIES	(253,755)	(770,775)	(1,423,600)
INVESTING ACTIVITIES:
Investment in joint venture	(10,000)	0	(270,000)
NET CASH USED IN FINANCING ACTIVITIES	(10,000)	0	(270,000)
FINANCING ACTIVITIES:
Proceeds from advances	263,648	769,141	1,694,472
NET CASH PROVIDED BY FINANCING ACTIVITIES	263,648	769,141	1,694,472
INCREASE (DECREASE) IN CASH	(107)	(1,634)	872
CASH, at the beginning of the period	979	2,613	0
CASH, at the end of the period	872	979	872
Cash paid during the period for:
Interest	0	0	0
Taxes	0	0	0
Noncash investing and financing transactions:
Issuance of stock for consulting services	0	210,000	210,000
Refinancing of demand notes to convertible notes payable	251,468	1,179,356	1,851,541
Issuance of stock for conversion of convertible notes payable	1,021,683	210,000	1,461,683
Acquisition of Global Cell Buyers for accrued liability and stock payable	$ 10,000	$ 0	$ 10,000